Fosun Pharma To Acquire India’s Gland Pharma Stake From KKR For $1.26B

This Data Is Locked!

This area is available only to Subscribers.

Shanghai Fosun Pharmaceutical (Group) Co. has signed a definitive agreement to acquire 86% of India’s Gland Pharma, a pure-play generic injectable pharmaceutical products firm backed... [DATA LOCKED]

UNLOCK DATA

Follow the Money & Subscribe for Access to the Best Data and Intelligence on Chinese Venture Capital Deals

Access Thousands of Data Points to Monitor Chinese Private Equity Deal Movement and Relationships

Already Have an Account?